相关临床试验
0
0 进行中
药物批准
2
批准总数
监管机构
1
监管机构数
成立时间
N/A
暂无试验阶段数据
暂无试验数据
暂无试验数据
**4.1. Therapeutic indications** Zinc supplementation solution in prolonged parenteral nutrition and in situations where a pronounced zinc deficiency may occur: e.g. severe malnutrition, hypercatabolism, digestive fistula, chronic diarrhoea.
<p><strong>4.1. Therapeutic indications</strong></p> <p>The treatment of epileptic patients who would normally be maintained on oral sodium valproate, and for whom oral therapy is temporarily not possible.<br> In the treatment of generalized or partial epilepsy, particularly with the following patterns of seizures:</p> <ul class="dash"> <li>absence</li> <li>myoclonic</li> <li>tonic-clonic</li> <li>atonic</li> <li>mixed</li> </ul> <p>As well as, for partial epilepsy:</p> <ul class="dash"> <li>simple or complex seizures</li> <li>secondary generalized seizures</li> <li>specific syndromes (West, Lennox-Gastaut)</li> </ul>
暂无资讯文章